SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 10-C
REPORT BY ISSUER OF SECURITIES QUOTED ON NASDAQ
INTERDEALER QUOTATION SYSTEM
Filed pursuant to Section 13 or 15(d) of the
Securities and Exchange Act of 1934 and Rule 13a-17
or 15d-17 thereunder
Curative Technologies, Inc
- ------------------------------------------------------------------------
(Exact name of issuer as specified in charter)
14 Research Way, E. Setauket, New York 11733
- -------------------------------------------------------------------------
(Address of principal executive offices)
Issuer's telephone number,including area code 516-689-7000
----------------
I. CHANGE IN NUMBER OF SHARES OUTSTANDING
Indicate any change (increase or decrease) of 5% or more in the number of
shares outstanding:
1. Title of security
--------------------------------------------------
2. Number of shares outstanding before the change
------------------
3. Number of shares outstanding after the change
-------------------
4. Effective date of change
----------------------------------------
5. Method of change: Public offering
Specify method (such as merger, acquisition, exchange,
distribution, stock split, reverse split, acquisition of stock
for treasury, etc.)
Give brief description of transaction
---------------------------------
----------------------------------------------------------------------
II. CHANGE IN NAME OF ISSUER
1. Name prior to change Curative Technologies, Inc.
---------------------------------
2. Name after change Curative Health Services, Inc.
-------------------------------------
3. Effective date of charter amendment changing name June 6,1996
-------------
4. Date of shareholder approval of change, if required May 30,1996
----------------
Date June 6,1996 /s/ John C. Prior Sr. V.P. Finance, C.F.O.
----------- ---------------------------------------------
(Officer's signature and title)
______________________________________________________________________________
